logo
Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

The Hill5 days ago
WASHINGTON (AP) — Shares of drugmaker Sarepta Therapeutics continued to sink Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following several patient deaths.
The decision, announced late Monday, comes just days after the company rebuffed FDA regulators in an extremely unusual decision that alarmed investors and analysts.
Sarepta CEO Doug Ingram said the company seeks a 'productive and positive' relationship with FDA and that 'maintaining that productive working relationship required this temporary suspension.'
The Cambridge, Massachusetts-based company said it would ' temporarily pause all shipments' of its gene therapy Elevidys for muscular dystrophy at the close of business Tuesday.
It's the latest in a series of highly irregular moves that have rocked company shares for weeks and forced it to lay off hundreds of staffers.
Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects boys and young men, resulting in early death. The one-time treatment was initially approved for boys age 4 and younger who could still walk. Last year, FDA expanded approval to older patients who are no longer able to walk.
The therapy was already under FDA scrutiny after two teenage boys died earlier this year from acute liver injury, a known side effect of the treatment. Then the company last week disclosed a third death with a different therapy: a 51-year-old patient who was enrolled in a company trial for another form of muscular dystrophy.
FDA responded on Friday by asking the company to immediately halt all shipments of Elevidys. Company executives initially refused, noting that the latest death was not tied to Elevidys, its best-selling product.
Wall Street analysts said the company made the right decision to cooperate.
Defying the FDA would have 'irreparably damaged the company's relationship with FDA under the current leadership and administration,' TD Cowen analyst Ritu Baral told investors in a note Tuesday.
Baral estimated the pause in distribution would last three to six months.
The FDA has the authority to pull drugs from the market, but the process can take months or even years. Instead, the agency usually makes an informal request and companies almost always comply. Even in the rare cases when drugmakers haven't cooperated, the FDA has prevailed after public hearings and appeals.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Upcoming Stock Splits This Week (July 28 to August 1)
Upcoming Stock Splits This Week (July 28 to August 1)

Business Insider

timean hour ago

  • Business Insider

Upcoming Stock Splits This Week (July 28 to August 1)

These are the upcoming stock splits for the week of July 28 to August 1, based on TipRanks' Stock Splits Calendar. A stock split is a corporate play that boosts the number of shares in circulation by handing out extras to existing shareholders, without changing the company's overall value. This reduces the price per share, making the stock more affordable and often more appealing to retail investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. But not all splits are about broadening appeal. Some companies flip the script with a reverse stock split, consolidating shares to boost the share price while shrinking the total share count. The company's market cap stays the same, but the higher price tag often helps meet listing standards like Nasdaq's minimum price rule, warding off the threat of delisting. Whether the goal is to court investors or stay in the game, these corporate maneuvers often send signals that smart traders are quick to pick up on. Let's take a look at the upcoming stock splits for the week. ChargePoint Holdings (CHPT) – ChargePoint is an electric vehicle (EV) charging infrastructure provider operating an extensive network of chargers and connected services. On July 9, ChargePoint announced a 1‑for‑20 reverse stock split scheduled to become effective on July 28. The split is intended to increase the per-share price and regain compliance with NYSE's minimum bid price requirement, after trading below the $1.00 threshold since January 2025. FOXO Technologies (FOXO) – Developing advanced payment-processing platforms for the dental and medical industries, FOXO is taking strategic action to stay compliant with NYSE American listing standards. On July 17, the board approved a 1‑for‑1.99 reverse stock split effective on July 27, with trading on a split‑adjusted basis starting July 28. Mersana Therapeutics (MRSN) – Mersana is a clinical-stage biotech developing antibody‑drug conjugates (ADCs) targeting cancer. On July 24, it announced a 1‑for‑25 reverse stock split, effective before market open on July 28. The split seeks to increase per‑share price to regain Nasdaq Global Select listing compliance after prolonged depressed stock price. Ikena Oncology (IKNA) – Ikena Oncology, am immuno‑oncology biotech company, received shareholder approval on July 15 for a 1-for-12 reverse stock split, to be implemented at the start of trading on July 28 – the same day it merges with Inmagene Biopharmaceuticals. Upon closing, the combined company will be rebranded as ImageneBio and begin trading on Nasdaq under the ticker symbol IMA. AgriFORCE Growing Systems (AGRI) – AgriFORCE Growing Systems, a Canada-based ag-tech and food systems company listed in the U.S., is going through a 1-for-9 reverse stock split. Shareholders gave the green light back on June 6, and the move will officially take effect when markets opened on July 28. The goal here is to get the share price back above Nasdaq's $1.00 minimum and stay in compliance with listing rules. Velo3D, Inc. (VLDX) – Velo3D, a leading innovator in metal 3D printing technology, is making a move to reposition itself in the market. On July 25, the company announced a 1-for-15 reverse stock split, set to take effect at the start of trading on July 28. To mark the change, Velo3D shares will temporarily trade under the ticker symbol VLDXD for 20 sessions before reverting back to VLDX. Senmiao Technology (AIHS) – Senmiao Technology, a U.S.-listed fintech and auto-finance company based in China, is streamlining its stock structure with a 1-for-10 reverse split. Announced on July 24, and set to take effect on July 29, the move aims to lift its share price to meet Nasdaq's listing standards. Silexion Therapeutics (SLXN) – Israel-based Silexion Therapeutics is a clinical-stage biotechnology company focused on developing personalized cancer vaccines and immuno-oncology therapies. On July 16, Silexion announced a 1-for-15 reverse stock split of its common shares, effective after market close on July 28, with trading on a split-adjusted basis beginning July 29. The reverse split is intended to boost the stock price and regain compliance with Nasdaq's minimum bid price requirement for continued listing. NaaS Technology (NAAS) – NaaS Technology is a China-based provider of EV charging services and software, listed on the Nasdaq. On July 14, the company announced a 1-for-4 reverse ADS split set to take effect on or about July 30. The move aims to lift the ADS price, ensure compliance with Nasdaq's minimum bid requirement, and strengthen its appeal to investors. Biodexa Pharmaceuticals (BDRX) – Biodexa Pharmaceuticals is a UK-based clinical-stage biotechnology company focused on developing treatments for diseases with unmet medical needs, including a Phase 3 trial for familial adenomatous polyposis and a Phase 2a trial for type 1 diabetes. On July 15, the company announced a 1-for-10 reverse ADR split, effective July 31. The goal is to raise the ADR trading price to meet Nasdaq's $1.00 minimum bid price requirement. Yoshiharu Global (YOSH) – Yoshiharu Global is a restaurant operator specializing in Japanese ramen and rolls, primarily located in Southern California and Nevada. On July 18, the board and shareholders approved a 4-for-1 forward stock split, record date July 28, with the additional shares distributed after market close on July 30, and trading on a post-split basis starting July 31. The aim is to increase stock liquidity and investor accessibility, making the shares more appealing to retail investors. TipRanks Stock Splits Calendar.

Trump ‘really likes' TikTok— but admin warns Chinese ownership not acceptable as dead deadline looms
Trump ‘really likes' TikTok— but admin warns Chinese ownership not acceptable as dead deadline looms

New York Post

timean hour ago

  • New York Post

Trump ‘really likes' TikTok— but admin warns Chinese ownership not acceptable as dead deadline looms

President Trump likes TikTok but the Chinese-owned short video app, used by some 170 million Americans, has to move to US ownership, Secretary of Commerce Howard Lutnick said on Sunday. 'The President really likes TikTok, and he said it over and over again, because, you know, it was a good way to communicate with young people,' Lutnick said in an interview on Fox News Sunday with Shannon Bream. 'But let's face it, you can't have the Chinese have an app on 100 million American phones, that is just not okay. So, it's got to move to American ownership, it's got to move to American technology, American algorithms,' he said. 'I know the President is positive towards TikTok, if it can move into American hands.' Advertisement 3 Commerce Secretary Howard Lutnick said Sunday that President Trump likes TikTok because 'it was a good way to communicate with young people.: FOX NEWS Lutnick's comments follow his warning last week that TikTok will have to stop operating in the U.S. if China does not approve a deal for the app. He told CNBC on Thursday that US must control the algorithm that makes the social media platform work. Advertisement TikTok parent ByteDance has a Sept. 17 deadline to divest the platform's US assets. Last month, President Trump extended by 90 days to Sept. 17, a deadline for China-based ByteDance to divest the US assets of TikTok. Trump's action took place despite a 2024 law that mandated a sale or shutdown by Jan. 19 of this year if there had not been significant progress. 3 President Trump has set a Sept. 17 deadline for Chinese firm ByteDance to divest TikTok's US assets. Getty Images 'China can have a little piece or ByteDance, the current owner, can keep a little piece. But basically, Americans will have control. Americans will own the technology, and Americans will control the algorithm,' Lutnick said. Advertisement 'If that deal gets approved, by the Chinese, then that deal will happen,' he added. 'If they don't approve it, then TikTok is going to go dark, and those decisions are coming very soon.' 3 A deal that was in the works this spring that would spin off TikTok's US operations into a new US-based firm stalled. Chidori_B – A deal had been in the works this spring that would spin off TikTok's US operations into a new US-based firm, majority-owned and operated by US investors. This stalled after China indicated it would not approve it following Trump's announcements of steep tariffs on Chinese goods. Trump has three times granted reprieves from federal enforcement of the law that mandated the sale or shutdown of TikTok that was supposed to take effect in January.

US and European Union announce a trade framework
US and European Union announce a trade framework

Boston Globe

timean hour ago

  • Boston Globe

US and European Union announce a trade framework

The U.S. and EU seemed close to a deal earlier this month to ease the prospect of dueling tariffs, but Trump instead threatened a 30% tariff rate. The agreement comes before a Trump administration deadline to impose tariffs on Friday. THIS IS A BREAKING NEWS UPDATE. AP's earlier story follows below. Advertisement EDINBURGH, Scotland (AP) — President Donald Trump headed into high-stakes talks Sunday with a top European official demanding fairer trade with the 27-member European Union and threatening steep tariffs to achieve that, while insisting the United States will not go below 15% import taxes. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Make-or-break talks could head off punishing U.S. tariffs — and promised retaliation from Europe — that could send shock waves through economies around the globe. European Commission chief Ursula von der Leyen, was seated next to Trump at his golf resort on the Scottish coast and called for a rebalancing of bilateral trade worth billions of dollars between the vital partners. Speaking to reporters before their private meeting began, she and Trump both put the chances of reaching an agreement at 50-50. Advertisement That is important because the White House says higher tariffs will kick in on Friday if both sides cannot find consensus. 'This is bigger than any other deal,' Trump said, suggesting they could hammer out an agreement in just a short time. The president also pledged to change what he characterized as 'a very one-sided transaction, very unfair to the United States.' 'I think both sides want to see fairness,' Trump said. Von der Leyen said the U.S. and EU combined have the world's largest trade volume, encompassing hundreds of millions of people and trillions of dollars. Trump said the stakes involved meant of making a deal, 'We should give it a shot.' Von der Leyen said Trump was 'known as a tough negotiator and dealmaker' which caused the president to interject with 'but fair.' She said that, if they are successful, 'I think it would be the biggest deal each of us has ever struck.' Trump called meeting with von der Leyen at his Turnberry golf course — where he played in the morning, an honor. 'I think the main sticking point is fairness,' he said while also noting, 'We've had a hard time with trade with Europe, a very hard time.' For months, Trump has threatened most of the world with large tariffs in hopes of shrinking major U.S. trade deficits with many key trading partners. More recently, he's hinted that any deal with the EU would have to 'buy down' the currently scheduled tariff rate of 30%. During remarks before the media Sunday, the president pointed to a recent U.S. agreement with Japan that set tariff rates for many goods at 15% and suggested the EU could agree to something similar. Advertisement Asked if he would be willing to accept tariff rates lower than that, Trump said 'no.' 'I'd like to see it resolved,' Trump said of a deal with Europe. 'But if it isn't, we'll have tariffs.' Of retaliation from Europe he said, 'They'll do what they have to do.' Their meeting came after Trump golfed for the second straight day at his Turnberry course, this time with a group that included sons Eric and Donald Jr. The president's five-day visit to Scotland is built around golf and promoting properties bearing his name. A small group of demonstrators at the course waved American flags and raised a sign criticizing British Prime Minister Keir Starmer, who plans his own Turnberry meeting with Trump on Monday. Other voices could be heard cheering and chanting 'Trump! Trump!' as he played nearby. On Tuesday, Trump will be in Aberdeen, in northeastern Scotland, where his family has another golf course and is opening a third next month. The president and his sons plan to help cut the ribbon on the new course. Joining von der Leyen were Maros Sefcovic, the EU's chief trade negotiator; Björn Seibert, the head of von der Leyen's Cabinet; Sabine Weyand, the commission's directorate-general for trade, and Tomas Baert, head of the trade and agriculture at the EU's delegation to the U.S. The U.S. and EU seemed close to a deal earlier this month, but Trump instead threatened the 30% tariff rate. The deadline for the Trump administration to begin imposing tariffs has shifted in recent weeks but is now firm, the administration insists. 'No extensions, no more grace periods. Aug. 1, the tariffs are set, they'll go into place, Customs will start collecting the money and off we go,' U.S. Commerce Secretary Howard Lutnick told 'Fox News Sunday.' He added, however, that even after that 'people can still talk to President Trump. I mean, he's always willing to listen.' Advertisement Lutnick said the EU 'needs to make a deal and wants to make a deal and they are flying to Scotland to make a deal with President Trump. The question is do they offer President Trump a good enough deal that is worth it for him to step off of the 30% tariffs that he set.' Without an agreement, the EU says it is prepared to retaliate with tariffs on hundreds of American products, ranging from beef and auto parts to beer and Boeing airplanes. If Trump eventually makes good on his threat of tariffs against Europe, it could make everything from French cheese and Italian leather goods to German electronics and Spanish pharmaceuticals more expensive in the United States. The U.S. and Britain, meanwhile, announced a trade framework in May and a larger agreement last month during the Group of Seven meeting in Canada. Trump says that deal is concluded and that he and Starmer will discuss other matters — though the White House has suggested it still needs some polishing.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store